References
- Lau CW, Martens P, Lambeets S, et al. Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patients. Acta Cardiol. 2019;74:405–412.
- Stoltzfus RJ. Defining iron-deficiency anemia in public health terms: time for reflection. J Nutr. 2001;131:565S–567S.
- Ponikowski P, Voors AA, Anker SD, et al.; for the Authors/Task Force Members; Document Reviewers. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.
- Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872–1880.